[1]
|
张蓓, 魏薇, 杨璨. AMH、DHEA-S、LH、FSH在多囊卵巢综合征患者血清中的表达及临床意义[J]. 贵州医药, 2022, 46(1): 126-127.
|
[2]
|
Bosch, E., et al. (2021) Reduced FSH and LH Action: Implications for Medically Assisted Reproduction. Human Reproduction, 36, 1469-1480. https://doi.org/10.1093/humrep/deab065
|
[3]
|
Le, M.T., et al. (2019) Exploration of the Role of Anti-Mullerian Hormone and LH/FSH Ratio in Diagnosis of Polycystic Ovary Syn-drome. Clinical Endocrinology, 90, 579-585. https://doi.org/10.1111/cen.13934
|
[4]
|
Blank, S.K., McCartney, C.R. and Marshall, J.C. (2006) The Origins and Sequelae of Abnormal Neuroendocrine Function in Polycystic Ovary Syn-drome. Human Reproduction Update, 12, 351-361.
https://doi.org/10.1093/humupd/dml017
|
[5]
|
Gross, K.M., Matsumoto, A.M. and Bremner, W.J. (1987) Differen-tial Control of Luteinizing Hormone and Follicle- Stimulating Hormone Secretion by Luteinizing Hormone-Releasing Hormone Pulse Frequency in Man. The Journal of Clinical Endocrinology and Metabolism, 64, 675-680. https://doi.org/10.1210/jcem-64-4-675
|
[6]
|
张红阳, 侯丽辉. 多囊卵巢综合征患者LH/FSH比值与临床及生化水平的相关性[J]. 医学研究杂志, 2019, 48(6): 64-67.
|
[7]
|
宋美杉, 连方. 基础LH/FSH比值对多囊卵巢综合征患者IVF-ET妊娠结局的影响[J]. 中国临床研究, 2021, 34(6): 774-776.
|
[8]
|
杨明明, 马生秀. 多囊卵巢综合征LH/FSH的特点以及其他临床指标的相关性[J]. 世界最新医学信息文摘, 2017, 17(68): 64-65.
|
[9]
|
Marcondes, J.A., et al. (2007) Metformin in Normal-Weight Hirsute Women with Polycystic Ovary Syndrome with Normal Insulin Sensitivity. Gynecological Endocrinology, 23, 273-278. https://doi.org/10.1080/09513590701192529
|
[10]
|
Dumesic, D.A., et al. (2015) Scientific Statement on the Diag-nostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocrine Re-views, 36, 487-525.
https://doi.org/10.1210/er.2015-1018
|
[11]
|
Woo, I., et al. (2015) Predictive Value of Elevated LH/FSH Ratio for Ovulation Induction in Patients with Polycystic Ovary Syndrome. The Journal of Reproductive Medicine, 60, 495-500.
|
[12]
|
杨元松. 血清FSH、LH、TSTO在多囊卵巢综合征患者中的表达及意义[J]. 实用妇科内分泌电子杂志, 2015, 2(3): 32-33.
|
[13]
|
岑振考, 叶恒君. 探讨多囊卵巢综合征患者检测血清LH、FSH、TSTO的意义[J]. 中国现代药物应用, 2015, 9(12): 29-30.
|
[14]
|
陈进萍. 血清FSH、LH、TSTO水平变化对多囊卵巢综合征不孕患者的临床价值[J]. 临床医学工程, 2017, 24(6): 811-812.
|
[15]
|
胡艳军, 杨永妮. 多囊卵巢综合征患者血清FSH、LH、睾酮检测的临床意义[J]. 包头医学院学报, 2016, 32(7): 92-93.
|
[16]
|
刘红霞. LH/FSH比值对多囊卵巢综合征的诊断价值分析[J]. 深圳中西医结合杂志, 2016, 26(8): 60-61.
|
[17]
|
潘莉娜. 血清黄体生成素与卵泡刺激素比值及雄激素受体基因多态性与多囊卵巢关系的探讨[J]. 贵州医药, 2018, 42(7): 774-776.
|
[18]
|
梅园园, 彭璇, 张小芬. 94例多囊卵巢综合征患者代谢特征观察[J]. 南昌大学学报(医学版), 2010, 50(7): 55-57.
|
[19]
|
刘雪连. 多囊卵巢综合症患者血浆leptin和血清T、E2、FSH、LH、PRL水平检测的临床意义[J]. 医学信息(中旬刊), 2011, 24(8): 3912-3913.
|
[20]
|
Kumar, N. and Agarwal, H. (2022) Early Clinical, Biochemical and Radiological Features in Obese and Non-Obese Young Women with Polycystic Ovarian Syndrome: A Comparative Study. Hormone and Metabolic Re-search, 54, 620- 624. https://doi.org/10.1055/a-1880-1264
|
[21]
|
Souza Dos Santos, A. (2015) The Impact of Body Mass on Inflammatory Markers and Insulin Resistance in Polycystic Ovary Syndrome. Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology, 31, 225-228. https://doi.org/10.3109/09513590.2014.976546
|
[22]
|
Mor, E., et al. (2004) The Insulin Resistant Subphenotype of Polycystic Ovary Syndrome: Clinical Parameters and Pathogenesis. American Journal of Obstetrics and Gynecology, 190, 1654-1660.
https://doi.org/10.1016/j.ajog.2004.02.052
|
[23]
|
周小静. 不同LH/FSH水平下PCOS患者的糖脂代谢特点及其中医证候分布规律的研究[D]: [硕士学位论文]. 兰州: 甘肃中医药大学, 2022.
|
[24]
|
王芳. 多囊卵巢综合征不孕患者血清HSP70、FSH、LH水平及与脂代谢关系[J]. 中国计划生育学杂志, 2022, 30(7): 1617-1620.
|
[25]
|
Banaszewska, B., et al. (2003) Incidence of Elevated LH/FSH Ratio in Polycystic Ovary Syndrome Women with Normo-and Hyperinsulinemia. Roczniki Akademii Medycznej w Bialymstoku, 48, 131-134.
|
[26]
|
Saadia, Z. (2020) Follicle Stimulating Hormone (LH:FSH) Ratio in Polycystic Ovary Syndrome (PCOS)—Obese vs. Non-Obese Women. Medical Archives, 74, 289-293. https://doi.org/10.5455/medarh.2020.74.289-293
|
[27]
|
Esmaeilzadeh, S., et al. (2014) Body Mass Index and Gonadotropin Hormones (LH & FSH) Associate with Clinical Symptoms among Women with Polycystic Ovary Syndrome. Global Journal of Health Science, 7, 101-106.
https://doi.org/10.5539/gjhs.v7n2p101
|
[28]
|
葛蕾. AMH、LH/FSH对多囊卵巢综合征患者的预测价值[J]. 中外医学研究, 2021, 19(2): 88-90.
|
[29]
|
谭健. AMH、LH、FSH对多囊卵巢综合征的诊断价值[J]. 实用妇科内分泌电子杂志, 2020, 7(6): 122-130.
|
[30]
|
Yanagihara, R. (2023) Compatible Cut-Off Values for Luteinizing Hormone and the Luteinizing Hormone/Follicle- Stimulating Hormone Ratio in Diagnostic Criteria of the Japan Society of Obstetrics and Gynecology for Polycystic Ovary Syndrome. The Journal of Obstetrics and Gynaecology Research, 49, 253-264.
https://doi.org/10.1111/jog.15423
|
[31]
|
Beydoun, H.A., et al. (2012) Relationship of Obesity-Related Disturbances with LH/FSH Ratio among Post-Meno- pausal Women in the United States. Maturitas, 71, 55-61. https://doi.org/10.1016/j.maturitas.2011.10.010
|